Antibiotic prophylaxis in a global surgical context

  • J Glasbey University of Birmingham


Surgical site infection (SSI) is a global problem, and has been highlighted as the foremost research priority for perioperative researchers across high-, middle- and low-income settings.1 Depending on the degree of intraoperative contamination, baseline patient risk and other infection control measures, as many as 50% of patients can suffer surgical wound infections within the 30-days after an operation.2 As a result, SSI has been the focus of several recent global initiatives including randomised controlled trials of health technologies,3 quality improvement bundle studies,4-6 and prospective cohort studies.2,7

The full article is available at

Author Biography

J Glasbey, University of Birmingham

NIHR Global Health Research Unit on Global Surgery, University of Birmingham, United Kingdom